Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00448474 · ClinicalTrials.gov registry record · NA

Development and Evaluation of A Mailed Arthritis Self-Management Program

A NA study of Rheumatoid Arthritis and Osteoarthritis, sponsored by University of North Carolina.

Completed
Registry status
NA
Development phase
900
Enrollment target
1
Study location

NCT00448474 is a NA study of Rheumatoid Arthritis and Osteoarthritis that has completed, run by University of North Carolina. The registered enrollment target is 900 participants, below the 4,686-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00448474, a NA study of Rheumatoid Arthritis and Osteoarthritis, has completed, sponsored by University of North Carolina.

COMPLETED
Registry status
NA
Development phase
900 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is twofold, to develop and test the effectiveness of a mailed arthritis self-management education intervention.

Interventions

  • BEHAVIORAL Mailed Arthritis Self-Management Education

Study Locations (1)

North Carolina

  • University of North Carolina at Chapel Hill - Chapel Hill

Trial Details

FieldValue
Enrollment Target 900 participants
Start Date 2005-11
Est. Completion 2006-07
Phase NA

Sponsor

University of North Carolina

14 total trials

What the Registry Record Tells You About NCT00448474

The ClinicalTrials.gov registry entry for NCT00448474 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 900 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,686-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (81% lower). The listed sponsor is University of North Carolina, which has 14 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Rheumatoid Arthritis appearing as the primary indexed condition, and to 1 intervention - of which Mailed Arthritis Self-Management Education is the first listed.

NCT00448474 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT00448474 about?

NCT00448474 is a clinical study titled "Development and Evaluation of A Mailed Arthritis Self-Management Program". The purpose of this study is twofold, to develop and test the effectiveness of a mailed arthritis self-management education intervention.

What is the current status of trial NCT00448474?

This trial is currently completed. It is a NA study. The enrollment target is 900 participants. The study started on 2005-11. Estimated completion is 2006-07.

What conditions does trial NCT00448474 study?

This clinical trial studies the following conditions: Rheumatoid Arthritis, Osteoarthritis.

What interventions are being tested in trial NCT00448474?

The interventions under investigation include: Mailed Arthritis Self-Management Education (BEHAVIORAL).

Who is sponsoring clinical trial NCT00448474?

This trial is sponsored by University of North Carolina, which has 14 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00448474 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Rheumatoid Arthritis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.